亚星化学终止收购山东天一化学：重组落幕业绩承压，标的隐忧早现

Core Viewpoint - Yaxing Chemical announced the termination of its significant asset restructuring plan, which involved acquiring 100% of Shandong Tianyi Chemical, due to changes in the market environment and disagreements on key issues such as asset valuation [1][2]. Group 1: Termination of Acquisition - The acquisition was planned for nearly two months but was ultimately halted due to a lack of consensus on core demands and asset valuation between the parties involved [1][2]. - The valuation date for the target asset was set for December 31, 2025, but the valuation work was not completed, leading to differing opinions on valuation judgments [2][3]. Group 2: Market Reaction - Following the announcement of the termination, Yaxing Chemical's stock price fell by 2.67% to 8.03 CNY per share on January 14, 2026, marking a decline of over 32% from its peak of 11.85 CNY since its resumption of trading on November 18, 2025 [1][2]. - Despite the recent decline, Yaxing Chemical's stock performance in 2025 was notable, with an annual increase of 93.3% [1][2]. Group 3: Financial Performance and Challenges - Yaxing Chemical reported a net loss of 144 million CNY in the first three quarters of 2025, surpassing the total loss of 97 million CNY for the entire year of 2024 [1][4]. - The termination of the acquisition means Yaxing Chemical will lose a key opportunity to improve its financial data, raising concerns about its ability to narrow losses or achieve profitability through its core business [4].